Chinese medicine is expected to obtain legal status of medicine in Europe
2022-10-10 07:05:29
| Due to the strict registration standards of the European Union, there is currently no Chinese medicine registered in Europe. Recently, in the Agreement on Cooperation in the Field of Chinese Medicine signed by China and France, the two sides reached an agreement to conduct extensive cooperation in basic research, clinical research, research and development of Chinese medicine, and exchanges and cooperation in enterprises. One of the important ones is to make Chinese medicines meet the requirements. EU standards. This initiative will not only strengthen the cooperation between the two countries in the field of health, but also accelerate the pace of "going out" of Chinese medicine. Traditional Chinese medicines that have been on the fringes of the European market are expected to obtain legal status as pharmaceuticals. Representatives from pharmaceutical companies such as Shanghai Leiyunshang Pharmaceutical Co., Ltd., Tianjin Tianshili Group, Peking University Unnamed Bioengineering Group, France's Piefarbe Company, Servier Pharmaceutical Co., Ltd., and Ai's Drug Release Technology Company attended the meeting and proposed cooperation. intention. Experts from scientific research institutions such as the China Academy of Chinese Medical Sciences introduced China's unique advantages in the field of traditional Chinese medicine, research on medicinal plants, research and development of Chinese medicines, and supervision of Chinese medicines. It is understood that Philippe Malecki, the head of China's Aifa Pharmaceutical Group, which is involved in the cooperation project on behalf of France, said that through this Sino-French cooperation, the company will apply drug release technology more widely to the research and development and production of traditional Chinese medicine. Changing the mode of administration optimizes the dosage form of traditional Chinese medicines to meet European registered standards. According to the data, the annual export volume of Chinese medicines exported to Europe in China was 120 million U.S. dollars in 2005. Europe has become one of the main export markets of Chinese traditional medicines. However, Chinese medicines exported to Europe only account for a small share of Chinese herbal medicines in this market. Faced with the huge European market, the situation facing Chinese medicine exports is becoming more and more severe. The EU Traditional Herbal Medicine Law stipulates that after April 2011, the sales of herbal medicines will be strictly managed. The Chinese medicines imported into the EU need to be proved to be used in EU member states for more than 15 years, and at the same time, they have been applied in third countries (such as China) for 30 years. The above can only be officially registered, and the Chinese medicine ingredients can only contain plants and several minerals. Traditional Chinese medicines generally include botanicals, animal drugs and minerals. Four years later, the EU implemented strict import management of Chinese medicine, which will make China's Chinese medicine industry face the shackles of internal and external attacks. Earlier, officials from the Ministry of Commerce in the UK issued a research report saying that after 2011, the export of Chinese medicine to the European market was “very pessimisticâ€. For a long time, almost all Chinese medicines have entered the EU and cannot be cleared by medicine. However, if the drug registration is not completed in the EU as early as possible, it will be rejected by the EU after the transition period. | |
Medical Hand Washing Sink,Hospital Surgical Scrubbing Sink,Hospital Scrubbing Station,Hospital Wash Sink
Taizhou Gaogang District Dixin Medical Equipment Co., Ltd. , https://www.dixinmedical.com